None of these studies, however, correlated metabolic patterns with mutations in BRAF. In BRAF-mutated CRC cell lines, e.g. alterations in glycolysis and glutamine utilization have been reported [15]. The gene discussed is BRAF; the disease is colorectal carcinoma.